blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2036573

EP2036573 - HLA binding peptides and their uses [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.10.2010
Database last updated on 15.06.2024
Most recent event   Tooltip08.10.2010Application deemed to be withdrawnpublished on 10.11.2010  [2010/45]
Applicant(s)For all designated states
IDM Pharma, Inc.
9 Parker, Suite 100
Irvine, CA 92618-1605 / US
[2009/12]
Inventor(s)01 / Sette, Alessandro
5551 Linda Rosa Avenue
La Jolla, CA 92037 / US
02 / Sidney, John
4218 Corte de la Siena
San Diego, CA 92130 / US
03 / Southwood, Scott
10679 Strathmore Drive
Santee, CA 92071 / US
 [2009/12]
Representative(s)Cripps, Joanna Elizabeth, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2009/12]Cripps, Joanna Elizabeth, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date08018213.217.06.1999
[2009/12]
Priority number, dateUS1998009858417.06.1998         Original published format: US 98584
[2009/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2036573
Date:18.03.2009
Language:EN
[2009/12]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.2009
ClassificationIPC:A61K39/145, C07K7/06
[2009/12]
CPC:
C07K14/70539 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/02 (EP); A61P37/04 (EP); A61K38/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2009/12]
TitleGerman:HLA-bindende Peptide und ihre Verwendungen[2009/12]
English:HLA binding peptides and their uses[2009/12]
French:Peptides se fixant au HLA et leurs utilisations[2009/12]
Examination procedure04.11.2008Examination requested  [2009/12]
02.11.2009Despatch of a communication from the examining division (Time limit: M06)
13.05.2010Application deemed to be withdrawn, date of legal effect  [2010/45]
17.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/45]
Parent application(s)   TooltipEP99928792.3  / EP1089757
Fees paidRenewal fee
04.11.2008Renewal fee patent year 03
04.11.2008Renewal fee patent year 04
04.11.2008Renewal fee patent year 05
04.11.2008Renewal fee patent year 06
04.11.2008Renewal fee patent year 07
04.11.2008Renewal fee patent year 08
04.11.2008Renewal fee patent year 09
04.11.2008Renewal fee patent year 10
22.06.2009Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
30.06.201012   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9324525  (UNIV LEIDEN [NL], et al) [X] 1,3-25 * page 6, line 19 * * table I * * page 11, line 14 * * claim 3 * * page 13, lines 28-32 *;
 [X]WO9741440  (UNIV LEIDEN [NL], et al) [X] 1,3-25 * page 85; tables XX,,PEPTIDES,A1,A3,A5 * * page 76 - page 77; tables XII,PEPTIDES,1,2,5,6,B *;
 [X]  - NIJMAN H W ET AL, "CHARACTERIZATION OF CYTOTOXIC T LYMPHOCYTE EPITOPES OF A SELF-PROTEIN, P53, AND A NON-SELF-PROTEIN, INFLUENZA MATRIX: RELATIONSHIP BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE BINDING AFFINITY AND IMMUNE RESPONSIVENESS TO PEPTIDES", JOURNAL OF IMMUNOTHERAPY, RAVEN PRESS, NEW YORK, US, (1993), vol. 14, no. 2, ISSN 1053-8550, pages 121 - 126, XP002015226 [X] 1,3-25 * abstract * * page 123; table 1 * * page 123, column R, paragraph 1 * * page 124; table 3 *
 [X]  - RAMMENSEE H-G ET AL, "MHC LIGANDS AND PEPTIDE MOTIFS: FIRST LISTING", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, (19950201), vol. 41, no. 4, ISSN 0093-7711, pages 178 - 228, XP000673045 [X] 1,3-25 * page 181, column 1, paragraph 3 - column 2, paragraph 2; figure 2 * * page 182, column 1, paragraph 2 - column 2, paragraph 1 * * page 182, column 2, paragraph 5 * * table 2 *

DOI:   http://dx.doi.org/10.1007/BF00172063
 [A]  - NIJMAN H W ET AL, "P53, A POTENTIAL TARGET FOR TUMOR-DIRECTED T CELLS", IMMUNOLOGY LETTERS, ELSEVIER BV, NL, (19940101), vol. 40, no. 2, ISSN 0165-2478, pages 171 - 178, XP000671427 [A] 1-25 * page 174, column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/0165-2478(94)90189-9
 [T]  - RAMMENSEE HANS-GEORG ET AL, "SYFPEITHI: Database for MHC ligands and peptide motifs", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, (199911), vol. 50, no. 3-4, ISSN 0093-7711, pages 213 & - 219, XP002183663 [T] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1007/s002510050595
 [T]  - KEOGH E ET AL, "Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 JUL 2001, (20010715), vol. 167, no. 2, ISSN 0022-1767, pages 787 - 796, XP002511412 [T] 1-25 * the whole document *
 [T]  - BARVE MINAL ET AL, "Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, (20080920), vol. 26, no. 27, ISSN 0732-183X, pages 4418 - 4425, XP009106492 [T] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1200/JCO.2008.16.6462
by applicantUS4235871
 US4501728
 US4690915
 US4722848
 US4837028
 US4844893
 WO9106309
 US5019369
 US5204253
 WO9324640
 US5279833
 WO9618372
 US5580859
 US5589466
 US5736142
    - SETTE ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 3296
    - SCHAEFFER ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 4649
    - DE BRUIJN ET AL., EUR. J. IMMUNOL., (1991), vol. 21, pages 2963 - 2970
    - PAMER ET AL., NATURE, (1991), vol. 353, pages 852 - 955
    - HUNKAPILLER ET AL., METHODS ENZYMOL., (1983), vol. 91, page 399
    - HUNT ET AL., SCIENCE, (1992), vol. 225, page 1261
    - SETTE ET AL., J. IMMUNOL., (1991), vol. 141, page 3893
    - TOWNSEND ET AL., CELL, (1990), vol. 62, page 285
    - MELIEF ET AL., EUR. J. IMMUNOL., (1991), vol. 21, page 2963
    - INABA ET AL., J. EXP. MED., (1987), vol. 166, page 182
    - BOOG, EUR. J. IMMUNOL., (1988), vol. 18, page 219
    - KÄRRE ET AL., NATURE, (1986), vol. 319, page 675
    - LJUNGGREN, EUR. J. IMMUNOL., (1991), vol. 21, pages 2963 - 2970
    - CERUNDOLO ET AL., NATURE, (1990), vol. 345, pages 449 - 452
    - SCHNEIDER, J. EMBRYOL. EXP. MORPHOL., (1927), vol. 27, pages 353 - 365
    - MERRIFIELD, SCIENCE, (1986), vol. 232, pages 341 - 347
    - BARANY; MERRIFIELD, The Peptides, ACADEMIC PRESS, (1979), pages 1 - 284
    - SPATOLA, CHEMISTRY AND BIOCHEMISTRY OF AMINO ACIDS, PEPTIDES AND PROTEINS, (1983), vol. VII
    - VERHOEF ET AL., EUR. J. DRUG METAB PHARMACOKIN., (1986), vol. 11, pages 291 - 302
    - DERES ET AL., NATURE, (1989), vol. 342, pages 561 - 564
    - MATTEUCCI ET AL., I-J. AM. CHEM. SOC., (1981), vol. 103, page 3185
    - VITIELLO, A. ET AL., J. CLIN. INVEST..., (1995), vol. 95, page 341
    - ELDRIDGE ET AL., MOLEC. IMMUNOL., (1991), vol. 28, pages 287 - 294
    - ALONSO ET AL., VACCINE, (1994), vol. 12, pages 299 - 306
    - JONES ET AL., VACCINE, (1995), vol. 13, pages 675 - 681
    - TAKAHASHI ET AL., NATURE, (1990), vol. 344, pages 873 - 875
    - HU ET AL., CLIN EXP IMMUNOL., (1998), vol. 113, pages 235 - 243
    - TAM, PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, pages 5409 - 5413
    - TAM, J. IMMUNOL. METHODS, (1996), vol. 196, pages 17 - 32
    - PERKUS ET AL., Concepts in vaccine development, (1996), page 379
    - CHAKRABARTI ET AL., NATURE, (1986), vol. 320, page 535
    - HU ET AL., NATURE, (1986), vol. 320, page 537
    - KIENY ET AL., AIDS BIOLTECHNOLOGY, (1986), vol. 4, page 790
    - TOP ET AL., J. INFECT. DIS., (1971), vol. 124, page 148
    - CHANDA ET AL., VIROLOGY, (1990), vol. 175, page 535
    - KOFLER ET AL., V. IMMUNOL. METHODS., (1996), vol. 192, page 25
    - ELDRIDGE ET AL., SEM. HEMATOL., (1993), vol. 30, page 16
    - FALO ET AL., NATURE MED., (1995), vol. 7, page 649
    - WARREN ET AL., ANNU. REV. IMMUNOL., (1986), vol. 4, page 369
    - GUPTA ET AL., VACCINE, (1993), vol. 11, page 293
    - REDDY ET AL., 1. IMMUNOL., (1992), vol. 148, page 1585
    - ROCK, IMMUNOL. TODAY, (1996), vol. 17, page 131
    - ULMER ET AL., SCIENCE, (1993), vol. 259, page 1745
    - ROBINSON I., VACCINE, (1993), vol. 11, page 957
    - SHIVER ET AL., Concepts in vaccine development, (1996), page 423
    - CEASE; BERZOFSKY, ANNU. REV. IMMUNOL., (1994), vol. 12, page 923
    - SZOKA ET AL., ANN. REV. BIOPHYS. BIOENG., (1980), vol. 9, page 467
    - WOLFF ET AL., SCIENCE, (1990), vol. 247, pages 1465 - 1468
    - MANNINO; GOULD-FOGERITE, BIOTECHNIQUES, (1988), vol. 6, no. 7, pages 682 - 691
    - FELGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 7413 - 7414
    - STOVER ET AL., NATURE, (1991), vol. 351, pages 456 - 460
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.